logo

For the Inventor, By the Inventor

Tokyo, Japan

Rie Miyauchi

This inventor holds 22 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Daiichi Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited. Active years: 2000-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rie Miyauchi. Retrieved from https://idiyas.com/inventor/rie-miyauchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 22.7

 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 67(Granted Patents)


Location History:

  • Tokyo, JP (2000 - 2013)
  • Edogawa-ku, JP (2007 - 2013)
  • Funabashi, JP (2015 - 2016)

Company Filing History:

goldMedal15 out of 200 
 
Daiichi Pharmaceutical Co., Ltd.
 patents
silverMedal7 out of 463 
 
Daiichi Sankyo Company, Limited
 patents

Years Active: 2000-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Protein Kinase Inhibitors
Aminopyrrolidine Derivatives
Pyrrolidine Derivative
Tricyclic Amine Derivatives
Optically Active Intermediates
Quinolonecarboxylic Acid
Dehalogeno-Compounds
Cis-Substituted Compounds
Aromatic Substituents
Cycloalkyl-Substituted
Tetrasubstituted Derivatives
22 patents (USPTO):Explore Patents
1. 9364466 - Heterocyclic compounds as protein kinase inhibitors (2016-06-14),
2. 8980911 - Heterocyclic compounds as protein kinase inhibitors (2015-03-17),
3. 8618094 - Fused substituted aminopyrrolidine derivative (2013-12-31),
4. 8476429 - Tri-, tetra-substituted-3-aminopyrrolidine derivative (2013-07-02),
5. 8455482 - Substituted pyrrolidine derivative (2013-06-04),
6. 8211910 - Tri-, tetra-substituted-3-aminopyrrolidine derivative (2012-07-03),
7. 7977327 - Substituted pyrrolidine derivative (2011-07-12),
8. 7902226 - Dehalogeno-compounds (2011-03-08),
9. 7842818 - Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof (2010-11-30),
10. 7723524 - 8-cyanoquinolonecarboxylic acid derivative (2010-05-25),
11. 7563805 - Tri-, tetra-substituted-3-aminopyrrolidine derivative (2009-07-21),
12. 7186843 - Aminomethylpyrrolidine derivatives having aromatic substituents (2007-03-06),
13. 7176313 - Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient (2007-02-13),
14. 6900225 - Quinolonecarboxylic acid derivative (2005-05-31),
15. 6762181 - Aminomethylpyrrolidine derivatives having aromatic substituents (2004-07-13),

Certainly! Here is the article about inventor Rie Miyauchi:

Title: Innovator Spotlight: Rie Miyauchi from Tokyo, Japan

Introduction:

Rie Miyauchi, a talented inventor hailing from Tokyo, Japan, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With an impressive portfolio of 22 patents, Miyauchi is a prominent figure in the world of innovative drug development.

Latest Patents:

Miyauchi's latest patents revolve around the development of heterocyclic compounds as protein kinase inhibitors. These compounds, represented by formula (I), have shown great potential in treating and preventing diseases associated with protein kinases, particularly within the Janus Kinase family. His inventions offer new avenues for therapeutic interventions and have the potential to impact the lives of many individuals.

Career Highlights:

Throughout his career, Rie Miyauchi has been associated with esteemed pharmaceutical companies such as Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His expertise and dedication have been instrumental in driving forward cutting-edge research and development initiatives within these organizations.

Collaborations:

In his professional journey, Miyauchi has collaborated with talented individuals such as Makoto Takemura and Hisashi Takahashi. Together, they have worked on innovative projects that have pushed the boundaries of scientific discovery and pharmaceutical advancements.

Conclusion:

Rie Miyauchi's relentless pursuit of innovation and his commitment to advancing the field of pharmaceuticals make him a standout inventor in the industry. His passion for developing novel solutions to complex medical challenges sets a high standard for aspiring inventors and researchers worldwide.

If you have any more specific requests or need further information, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…